Detail page

Knowledge Web

Person

Wilko Weichert (1970-2023)

Arzt

Name	Wilko Weichert
Time	1970-2023 (Date of birth and death)
Place	Tübingen (Geburtsort) Heidelberg (Wirkungsort) München (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession)
Variant	Wilko Christian Weichert W. Weichert
Related	Universität Heidelberg. Pathologisches Institut (02/2010-02/2016) Nationales Centrum für Tumorerkrankungen (2013-2015) Technische Universität München. Fakultät für Medizin (2016-)
Further information	Diss. Fachbereich Humanmedizin; Leitender Oberarzt, Stellvertretender Ärztlicher Direktor, Pathologisches Institut, Universitätsklinikum Heidelberg; Institute of Pathology, Technische Universität München (TUM), Munich
Source	Quelle: http://www.sfb824.de/de/Team/Projektleiter/members/Weichert_Wilko/Lebenslauf.pdf (Stand: 19.11.2019)
Record type	Person
GND-Identifier	123509106
Record ID	123509106
Involved in show all Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations Low microsatellite instability: A distinct instability type in gastric cancer? Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification Characterization of hormone receptor and HER2 status in breast cancer using mass spectrometry imaging Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD) Struktur und Inhalt der EU-IVDR : Bestandsaufnahme und Implikationen für die Pathologie Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell of origin Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174–184] Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen = Diagnosis and therapy of tumors with NTRK gene fusion Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas : Incidental Finding or Prognostic Biomarker? PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315) Combined inhibition of epigenetic readers and transcription initiation targets the EWS-ETS transcriptional program in Ewing sarcoma Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen Impact of tumor localization and molecular subtypes on the prognostic and predictive significance of p53 expression in gastric cancer Induktion einer gegen den Tumor gerichteten Immunität zur Verbesserung des Langzeitüberlebens nach kurativer Resektion eines nicht-kleinzelligen Lungenkarzinoms Proteomische Tools zur Untersuchung physiologischer und pathophysiologischer Prozesse Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma Defective homologous recombination DNA repair as therapeutic target in advanced chordoma Defective homologous recombination DNA repair as therapeutic target in advanced chordoma Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics Proteomics in Pathology Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized 13C-MRSI Genetic Profiling of Cancers of the Digestive System: Biological Insights and Clinical Implications Pharmacoproteomic characterisation of human colon and rectal cancer Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts Das hepatische Blutgefäßnetzwerk und angiokrine Signalwege in Leberphysiologie, neoplastischen und nichtneoplastischen Lebererkrankungen Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer Klinisch-pathologische Charakterisierung von Karzinomen der Gaumenmandel Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma Pharmacoproteomic characterisation of human colon and rectal cancer Grading von Tumoren der Kopf‑Hals‑Region Stellungnahme der DGP und der AG Thorakale Onkologie der AG Onkologie/Deutsche Krebsgesellschaft e. V. zur ALK-Testung beim NSCLC : Immunhistochemie und/oder FISH? Dauerhafte Remission unter dualer HER2-Blockade mit Trastuzumab und Pertuzumab bei metastasiertem Gallenblasenkarzinom CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma Establishment of a patient-derived orthotopic osteosarcoma mouse model Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases Bericht des Vorsitzenden der Arbeitsgruppe für Kopf-/Halspathologie der Deutschen Gesellschaft für Pathologie : Jahresaktivitäten 2014/2015 Grenzen, Pitfalls und Perspektiven der diagnostischen massiven parallelen Sequenzierung Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma Association of angiogenic factors with prognosis in esophageal cancer ROS1-Translokationen im nicht-kleinzelligen Lungenkarzinom Association of angiogenic factors with prognosis in esophageal cancer CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer Pathologie als Gatekeeper : Neue histopathologische Klassifikation des NSCLC und molekulare Diagnostik

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Wilko Weichert (1970-2023)

Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations

Low microsatellite instability: A distinct instability type in gastric cancer?

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

Characterization of hormone receptor and HER2 status in breast cancer using mass spectrometry imaging

Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging

Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma

Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics

Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)

Struktur und Inhalt der EU-IVDR : Bestandsaufnahme und Implikationen für die Pathologie

Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell of origin

Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174–184]

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen = Diagnosis and therapy of tumors with NTRK gene fusion

Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas : Incidental Finding or Prognostic Biomarker?

PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Combined inhibition of epigenetic readers and transcription initiation targets the EWS-ETS transcriptional program in Ewing sarcoma

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

Impact of tumor localization and molecular subtypes on the prognostic and predictive significance of p53 expression in gastric cancer

Induktion einer gegen den Tumor gerichteten Immunität zur Verbesserung des Langzeitüberlebens nach kurativer Resektion eines nicht-kleinzelligen Lungenkarzinoms

Proteomische Tools zur Untersuchung physiologischer und pathophysiologischer Prozesse

Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics

Proteomics in Pathology

Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized 13C-MRSI

Genetic Profiling of Cancers of the Digestive System: Biological Insights and Clinical Implications

Pharmacoproteomic characterisation of human colon and rectal cancer

Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts

Das hepatische Blutgefäßnetzwerk und angiokrine Signalwege in Leberphysiologie, neoplastischen und nichtneoplastischen Lebererkrankungen

Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer

Klinisch-pathologische Charakterisierung von Karzinomen der Gaumenmandel

Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

Pharmacoproteomic characterisation of human colon and rectal cancer

Grading von Tumoren der Kopf‑Hals‑Region

Stellungnahme der DGP und der AG Thorakale Onkologie der AG Onkologie/Deutsche Krebsgesellschaft e. V. zur ALK-Testung beim NSCLC : Immunhistochemie und/oder FISH?

Dauerhafte Remission unter dualer HER2-Blockade mit Trastuzumab und Pertuzumab bei metastasiertem Gallenblasenkarzinom

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

Establishment of a patient-derived orthotopic osteosarcoma mouse model

Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma

Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases

Bericht des Vorsitzenden der Arbeitsgruppe für Kopf-/Halspathologie der Deutschen Gesellschaft für Pathologie : Jahresaktivitäten 2014/2015

Grenzen, Pitfalls und Perspektiven der diagnostischen massiven parallelen Sequenzierung

Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma

Association of angiogenic factors with prognosis in esophageal cancer

ROS1-Translokationen im nicht-kleinzelligen Lungenkarzinom

Association of angiogenic factors with prognosis in esophageal cancer

CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab

Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique

Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Pathologie als Gatekeeper : Neue histopathologische Klassifikation des NSCLC und molekulare Diagnostik